Literature DB >> 24286088

Contrast enhanced ultrasound and magnetic resonance imaging in hepatocellular carcinoma diagnosis.

Cristiana I Dumitrescu1, Ioana A Gheonea, Larisa Săndulescu, Valeriu Surlin, Adrian Săftoiu, Daniela Dumitrescu.   

Abstract

BACKGROUND: The new developments in imaging technology, including contrast enhanced ultrasound (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI), allow a better diagnosis of both malignant and benign liver lesions.
MATERIAL AND METHODS: A retrospective trial of 126 patients was conducted in the Gastroenterology and Imaging Departments of the University of Medicine and Pharmacy Craiova, Romania. CEUS and MRI were the imaging techniques used for diagnosis of focal liver lesions (FLL), especially for hepatocellular carcinoma (HCC). Histopathology was used only in 15 cases. For each method of investigation we calculated the sensitivity, specificity, positive and negative predictive values (PPV and NPV), positive and negative likelihood ratio (+LR, -LR), accuracy and we compared the ROC curves. Statistical analysis also included the Chi-square and Kappa tests.
RESULTS: Seventy six cases were diagnosed as HCC, with average size of 5.2±3.3 cm in diameter. The sensitivity and specificity were 71.4% and 95.6% for CEUS and 91.4%, 98.9% respectively, for MRI. When comparing the ROC curves, we found a higher area under curve for MRI (0.952) then for CEUS (0.835) (p=0.005), and 95% confidence interval of 0.0343 to 0.199. No statistically significant difference in diagnosis of FLL was found between CEUS and MRI (p > 0.05) and the agreement between the two imaging techniques was good (k = 0.78).
CONCLUSIONS: CEUS can be used as the first step in the diagnosis of liver lesions, but MRI remains the gold standard diagnostic method for liver tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24286088     DOI: 10.11152/mu.2013.2066.154.cd2

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  9 in total

Review 1.  Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Mirella Fraquelli; Tin Nadarevic; Agostino Colli; Cristina Manzotti; Vanja Giljaca; Damir Miletic; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

Review 2.  Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Agostino Colli; Vanja Giljaca; Mirella Fraquelli; Giovanni Casazza; Cristina Manzotti; Davor Štimac; Damir Miletic
Journal:  Cochrane Database Syst Rev       Date:  2022-05-06

Review 3.  Latest developments in precancerous lesions of hepatocellular carcinoma.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang; Jing Zhao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

4.  Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.

Authors:  Juanjuan Zhang; Yanyan Yu; Ying Li; Lunshou Wei
Journal:  Oncotarget       Date:  2017-08-07

5.  Diagnostic value of hepatic artery perfusion fraction combined with TGF-β in patients with hepatocellular carcinoma.

Authors:  Qingxu Liu; Yan Gao; Yongxue Wang; Jiexin Du; Qiang Yin; Kewei Shi
Journal:  Oncol Lett       Date:  2019-04-08       Impact factor: 2.967

6.  Discrepancy of contrast-enhanced ultrasonographic pattern with two contrast agents in steatohepatitic subtype hepatocellular carcinoma: A case report.

Authors:  Jiang Bo; Kong BeiNing; Fei Xiang; Wan XinKun; Luo YuKun
Journal:  Radiol Case Rep       Date:  2022-04-05

7.  Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.

Authors:  Dan Yang; Rui Li; Xiao-Hang Zhang; Chun-Lin Tang; Kuan-Sheng Ma; De-Yu Guo; Xiao-Chu Yan
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

8.  Increased EXT1 gene copy number correlates with increased mRNA level predicts short disease-free survival in hepatocellular carcinoma without vascular invasion.

Authors:  Sheng Dong; Yifeng Wu; Shigang Yu; Yinxi Yang; Lijun Lu; Shurong Fan
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

9.  Value of ultrasound combined with MRI in the diagnosis of primary and recurrent hepatocellular carcinoma.

Authors:  Xiaoli Ji; Shisheng Zhou; Peng Yang; Faqin Liu; Yan Li; Hong Li
Journal:  Oncol Lett       Date:  2019-10-02       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.